Tinea Nigra Clinical Presentation
- Author: Robert A Schwartz, MD, MPH; Chief Editor: William D James, MD more...
History
Generally, patients with tinea nigra are asymptomatic. Rarely, pruritus may be reported. The absence of any discomfort often delays the patient's decision to seek medical advice.
Patients who live in the inland areas of the United States generally report a history of foreign travel, most often to the Caribbean islands. In addition, patients may have acquired this infection while visiting the tropical regions of Asia or Africa. Those who reside in the coastal regions do not necessarily report any travel outside of the United States.
Uezato et al[10] reported a case of tinea nigra palmaris from Okinawa, Japan on the left palm of a 13-year-old girl, who had noticed the pigmented, asymptomatic macule on her left palm approximately 4-5 years prior to presentation. She stated the lesion became lighter after a bath and darkened some time later. Physical examination revealed a 4 X 5-cm, dark brown, and irregularly shaped macule.
Histological findings were reported as follows: "Direct potassium hydroxide (KOH) microscopic examination from skin scrapings revealed branched brown hyphae with light brown septa. A fungal culture on Sabouraud's agar media produced wet, medium brown, yeast-like colonies, the surface of which later became black and shiny. A slide culture disclosed light brown, elliptic or peanut-shaped conidia comprised of one to two ampullaceous cells. Scanning electron microscopic examination of the conidia showed both annellation [sic] conidia with lunate bud scars and sympodial conidiogenesis."
DNA was extracted from separately cultured fungi, and polymerase chain reaction with primers specific to H werneckii was performed; results showed positive bands. Direct sequencing was performed with the DNA segments from the positive bands. Type C H werneckii was determined to be the causative fungus, based on the base sequences obtained, and tinea nigra due to H werneckii was diagnosed.
Physical
Tinea nigra is characterized by the presence of a painless brown-to-black macule, as shown in the image below. The macule appears insidiously as a small dark spot.
Tinea nigra, evident as a painless cluster of brown-to-black macules. Courtesy of Dr. Peter Santalucia. Hyperpigmentation of the macule ranges from light brown to black discoloration, resembling silver nitrate or India ink stains. The borders are typically discrete. The pigmentary change may appear mottled or velvety.
The lesions are typically solitary, although more than one lesion can be present. Solitary lesions are typically located on the palmar surfaces of the hands or plantar surfaces of the feet, and they may extend to the fingers or toes, respectively. Other areas of the body, such as the neck and chest wall, are more rarely affected.
The shape of the lesion varies, and they may appear ovoid, round, or irregular. The lesion slowly grows over weeks to months. The size may range from a few millimeters to several centimeters in diameter, depending on the duration of the infection.
Other physical findings, such as erythema or induration, are absent. Rarely, scaling is present. Dermoscopic examination may facilitate the in vivo diagnosis of tinea nigra.[11] Manual and digital dermatoscopic images show irregularly distributed dark brown-pigmented dots with a filamentous aspect.[12]
Although tinea nigra is often easily diagnosed on clinical grounds alone,[13] the use of dermoscopy for palmar or plantar pigmentation may enhance the recognition of tinea nigra.[14] Characteristic features evident on dermoscopy are superficial fine, wispy, light-brown strands forming a reticularlike patch with a uniform brown color. These strands do not follow the furrows and ridges normally observed in this skin.
Causes
Tinea nigra is due to infection by the fungus, P werneckii, which is classified in the family Dematiaceae, class Hyphomycetes, phylum Deuteromycota. Infection occurs after inoculation subsequent to trauma. The dermatomycosis tends to occur in areas with an increased concentration of eccrine sweat glands. Hyperhidrosis appears to be a risk factor for this disease.
Schwartz RA. Superficial fungal infections. Lancet. Sep 25-Oct 1 2004;364(9440):1173-82. [Medline].
Perez C, Colella MT, Olaizola C, Hartung de Capriles C, Magaldi S, Mata-Essayag S. Tinea nigra: report of twelve cases in Venezuela. Mycopathologia. Oct 2005;160(3):235-8. [Medline].
Badali H, Carvalho VO, Vicente V, et al. Cladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol. Feb 2009;47(1):51-62. [Medline].
Blank H. Tinea nigra: a twenty-year incubation period?. J Am Acad Dermatol. Jul 1979;1(1):49-51. [Medline].
Lenassi M, Vaupotic T, Gunde-Cimerman N, Plemenitas A. The MAP kinase HwHog1 from the halophilic black yeast Hortaea werneckii: coping with stresses in solar salterns. Saline Systems. 2007;3:3. [Medline].
Rezusta A, Gilaberte Y, Betran A, Gene J, Querol I, Arias M, et al. Tinea nigra: a rare imported infection. J Eur Acad Dermatol Venereol. Jan 2010;24(1):89-91. [Medline].
Chen GY, Cheng YW, Wang CY, Hsu TJ, Hsu MM, Yang PT, et al. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: a community-based clinical survey. J Formos Med Assoc. Jan 2008;107(1):21-9. [Medline].
Hall J, Perry VE. Tinea nigra palmaris: differentiation from malignant melanoma or junctional nevi. Cutis. Jul 1998;62(1):45-6. [Medline].
Tseng SS, Whittier S, Miller SR, Zalar GL. Bilateral tinea nigra plantaris and tinea nigra plantaris mimicking melanoma. Cutis. Oct 1999;64(4):265-8. [Medline].
Uezato H, Gushi M, Hagiwara K, Kayo S, Hosokawa A, Nonaka S. A case of tinea nigra palmaris in Okinawa, Japan. J Dermatol. Jan 2006;33(1):23-9. [Medline].
Zalaudek I, Giacomel J, Cabo H, Di Stefani A, Ferrara G, Hofmann-Wellenhof R, et al. Entodermoscopy: a new tool for diagnosing skin infections and infestations. Dermatology. 2008;216(1):14-23. [Medline].
Paschoal FM, de Barros JA, de Barros DP, de Barros JC, Filho CD. Study of the dermatoscopic pattern of tinea nigra: report of 6 cases. Skinmed. Nov-Dec 2010;8(6):319-21. [Medline].
Muir J. Tinea nigra and dermoscopy. Australas J Dermatol. Feb 2012;53(1):e14; author reply e15. [Medline].
Piliouras P, Allison S, Rosendahl C, Buettner PG, Weedon D. Dermoscopy improves diagnosis of tinea nigra: a study of 50 cases. Australas J Dermatol. Aug 2011;52(3):191-4. [Medline].
Tilak R, Singh S, Prakash P, Singh DP, Gulati AK. A case report of tinea nigra from North India. Indian J Dermatol Venereol Leprol. Sep-Oct 2009;75(5):538-9. [Medline].
Rossetto AL, Cruz RC. Spontaneous cure in a case of Tinea nigra. An Bras Dermatol. Feb 2012;87(1):160-2. [Medline].
Burke WA. Tinea nigra: treatment with topical ketoconazole. Cutis. Oct 1993;52(4):209-11. [Medline].
Marks JG Jr, King RD, Davis BM. Treatment of tinea nigra palmaris with miconazole. Arch Dermatol. Mar 1980;116(3):321-2. [Medline].
Shannon PL, Ramos-Caro FA, Cosgrove BF, Flowers FP. Treatment of tinea nigra with terbinafine. Cutis. Sep 1999;64(3):199-201. [Medline].
Babel DE, Pelachyk JM, Hurley JP. Tinea nigra masquerading as acral lentiginous melanoma. J Dermatol Surg Oncol. May 1986;12(5):502-4. [Medline].

